期刊文献+

116例人苍白杆菌的耐药率及临床危险因素分析 被引量:8

The analysis of resistance rate and risk factors of 116 cases of Ochrobactrum anthropi
下载PDF
导出
摘要 目的探讨人苍白杆菌血流感染的临床特点、危险因素分布及耐药特点,为有效预防和治疗该菌血流感染提供科学依据。方法回顾性统计分析2012年1月至2014年12月广州医学院第三附属医院北院收治的116例血液细菌培养为人苍白杆菌感染的临床和检验资料。结果本研究血流感染人苍白杆菌病例中,性别分布为:男性占52.59%(61/116),女性占47.41%(55/116);年龄分布为:6岁以下47.41%(55/116),50岁以上22.41%(26/116),19~49岁17.24%(20/116),6~18岁12.93%(15/116);科室分布为:儿科占45.69%(53/116),重症监护病房(ICU)占28.45%(33/116),移植科占9.48%(11/116),肾内科占6.03%(7/116),泌尿外科占3.45%(4/116),神经内科占0.86%(1/116)。人苍白杆菌对青霉素和第1、2、3代头孢菌素类、氨曲南耐药性较高,对4代头孢菌素头孢吡肟的敏感性较高,对亚胺培南、环丙沙星100.0%敏感。结论人苍白杆菌对大多数β-内酰胺类抗菌药物耐药率较高,治疗应首选喹诺酮类、碳青霉烯类等抗菌药物。预防该菌的医院血流感染,应尽量减少不必要的侵入性操作,加强抗菌药物的合理规范使用。 Objective To investigate the clinical characters,distribution of risk factors and drug resistance of blood infection with Ochrobactrum anthropi,and to provide the clinical evidence for the correct treatment.Methods Infection clinical and test datas were collected from 116 cases of blood culture Ochrobactrum anthropi in the Third Affiliated Hospital of Guangzhou Medical College from January 2012 to December 2014.The datas were reviewed and analyzed.Results The sex distribution:in the male,which accounted for 52.59%(61/116).the female accounted for 47.41%(55/116);The age distribution of blood infection of Ochrobactrum anthropi showed as following:the children under 6accounted for 47.41%(55/116).The elder people over 50 accounted for22.41%(26/116),19-49 years old accounted for 17.24%(20/116),6-18 years old accounted for 12.93%(15/116);The department distribution of blood infection of Ochrobactrum anthropi showed as following:in the pediatrics,which accounted for 45.69%(53/116)and the intensive care unit(ICU)accounted for 28.45%(33/116),the transplant department accounted for 9.48%(11/116),the renal department of internal medicine accounted for 6.03%(7/116),the urology surgery accounted for 3.45%(4/116),the internal medicine-neurology accounted for 0.86%(1/116).Ochrobactrum anthropi was resistant to penicillin the first,second,third generation cephalosporins and aztreonam,but sensitive to the fourth generation cephalosporins cefepime,imipenem and ciprofloxacin.Conclusion Ochrobactrum anthropi has a high antibiotic resistance toβ-lactam antibiotics,the most effective antimicrobial agents for treating are quinolones and carbapenems.To prevent the bacteria nosocomial blood infections,unnecessary invasive procedures should be minimized,strengthening the rational and specification use of antimicrobial drugs is necessary.
出处 《国际检验医学杂志》 CAS 2016年第10期1315-1317,共3页 International Journal of Laboratory Medicine
基金 广东省医学科研基金立项课题(A2013302)
关键词 人苍白杆菌 耐药率 血流感染 危险因素 Ochrobactrum anthropi resistance rates blood infection risk factors
  • 相关文献

参考文献12

  • 1Clinical and Laboratory Standards Institute. Performance stand- ards for antimicrobial susceptibility testing[S]. Twenty-Fouth in-formational Supplement. MlOO-S24,CLSI,2014.
  • 2Appelbaum PC, Campbell DB. Pancreatic abscess associated with Achromobacter group Vd biovar 1 [ J ]. J Clin Microbiol, 1980,12 (2) :282-283.
  • 3Ortega-Gonzilez DK, Cristiani-Urbina E, Flores Ortiz CM, et al. Evaluation of the removal of pyrene and fluoranthene by Ochrobactrum anthropi,Fusarium sp. and their coculture[J]. Ap pl Biochem Biotechnol,2015 ,175(2) :1123-1138.
  • 4Franci P,Dotto G,Cattai A,et al. Lethal septic shock after dental scaling in a healthy dog due to Ochrobactrum anthropi contamina- ted propoIol[J]. J Small Anim Pract,2015,56(5) :345-347.
  • 5刘健龙,张洁,聂波丽,李先斌,周舟,刘建良.91例儿童人苍白杆菌败血症病原菌及耐药性分析[J].实用预防医学,2010,17(3):447-448. 被引量:9
  • 6伍媛.ICU院内感染调查及危险因素分析[J].中外医疗,2014,33(8):9-10. 被引量:2
  • 7Kumar S, Kapoor S, Chadha S, et al. Ochrobactrum anthropi septi- cemia and pneumonia in a preterm, small for gestational age infant with multiple congenital anomalies[J]. Indian J Pathol Microbiol, 2013,56(3):317 318.
  • 8王书侠,张家明,施建丰,梅国勇,葛高霞.人苍白杆菌引起泌尿系感染及耐药性分析[J].医学研究生学报,2012,25(8):893-894. 被引量:9
  • 9Chen H J, Lee MS, Lai JY, et al. Development of a loop-mediated i sothermal amplification method for the rapid detection of the diox in-degrading bacterium Ochrobaetrum anthropi in soil[J]. J Envi ron Manage, 2015,160:263 270.
  • 10郑慧丽,付辉,刘丽,樊华,白光锐,李敬文.同时产ESBLs和AmpC酶革兰氏阴性杆菌基因型和耐药性分析[J].齐齐哈尔医学院学报,2014,35(12):1783-1785. 被引量:3

二级参考文献41

  • 1周华,凌丽燕,杨青,俞云松,陈亚岗,李兰娟,郑树森.人苍白杆菌耐药性及AmpC酶研究[J].中华检验医学杂志,2005,28(4):378-380. 被引量:22
  • 2黄华,彭常军,李彬,徐传彬,高国全,陆淼泉.人苍白杆菌分离株部分生物学性状的研究[J].中华检验医学杂志,2005,28(10):1022-1024. 被引量:6
  • 3李虹玲,刘文恩.SHV型超广谱β-内酰胺酶的研究进展[J].实用预防医学,2007,14(1):253-255. 被引量:9
  • 4陶方明.从痰中分离出多重耐药的人苍白杆菌1株[J].检验医学与临床,2007,4(4):341-342. 被引量:1
  • 5储从家,孔繁林,吴惠玲.83例新生儿血培养阳性结果与临床分析[J].中国感染控制杂志,2007,6(4):253-254. 被引量:13
  • 6Deliere E,VuThien H, Levy V, et al. Epidemiological investigation of Ochrobactrum anthropi strains isolated from a haematology unit[J ]. J Hosp Infect, 2000,44 : 173 - 178.
  • 7NCCLS. Performance standards for antimicrobial susceptibility test [ S]. Ninth informational supplement, NCCLS, 1999.36-75.
  • 8Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol,2000, 38: 1791-1796.
  • 9Higgins CS, Avison MB, Jamieson L, et al. Characterization, cloning and sequence analysis of the inducible Ochrobactrum anthropi AmpC beta-lactamase. J Antimicrob Chemother, 2001, 47: 745-754.
  • 10Deliere E, Vu Thien H, Levy V, et al. Epidemiological investigation of Ochrobactrum anthropi strains isolated from a haematology unit. J Hosp Infect, 2000, 44:173-178.

共引文献43

同被引文献37

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部